Global Multiplex Assays Market - Industry Trends and Forecast to 2026

  • In Vitro Diagnostics
  • Published Report
  • Nov 2018
  • Global
  • 329 Pages
  • No of Tables: 54
  • No of Figures: 310

Global Multiplex Assays Market, By Products & Services (Reagents & Consumables, Instruments & Accessories, Software & Services), Type (Nucleic Acid Multiplex Assays, Protein Multiplex Assays, Cell-Based Multiplex Assays), Technology (Protein Microarray, Polymerase Chain Reaction, Multiplex Real-Time PCR, Flow Cytometry, Fluorescence Detection, Luminescence, Others), Application (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)- Industry Trends and Forecast to 2026

A Multiplex Assay is a type of immunoassay that uses magnetic beads or non-magnetic beads to determine multiple analyte in a single sample. A multiplex assay is as similar as that of an ELISA but here in multiplex assays, beads are present that are useful in binding the capture antibody. Multiplex assays are common because of their benefits nowadays in research than in clinical settings.

Protein immunoassays give data regarding quantities and forms of endogenous proteins in a given sample. Uniplex enzyme immunoassays such as enzyme-linked immunosorbent assay (ELISA) used for protein measurement from past years but they are time consuming and found to be more costly. When comparing ELISA with multiplex assays, multiplex assays offer more accurate quantitative information in a single analysis for number of analysis.

Global multiplex assays market is expected to reach a healthy CAGR of 7.5% in the forecast period of 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Segmentation: Global Multiplex Assays Market

A global multiplex assay market is categorized into five notable segments which are products & services, type, technology, application and end user.

  • On the basis of product & services the market is segmented into reagents & consumables, instruments & accessories and software and services.

    • In 2019, reagents & consumables segment is expected to dominate the global multiplex assays market with 64.1% market share and is expected to grow at the highest CAGR of 7.8% in the forecast period of 2019 to 2026.

  • In September 2014, F. Hoffmann-La Roche Ltd launched new fully automated molecular diagnostic systems named as cobas 6800/8800 Systems. These systems offer results in a very short time along with highest testing capacity. With this launch the company has increased their product portfolio in market in diagnostics field.
  • On the basis of type, the market is segmented into protein multiplex assays, nucleic acid multiplex assays and cell-based multiplex assays. Protein multiplex assays are sub-segmented into planar protein assays and bead-based protein assays. Nucleic acid multiplex assays are sub-segmented into planar nucleic acid assays and bead-based nucleic acid assays. In 2019, a nucleic acid multiplex assay segment is expected to dominate the global multiplex assays market with 48.5% market share and is expected to grow at the highest CAGR of 8.0% in the forecast period of 2019 to 2026.

    • In June 2015, Abcam plc, launched a range of multiplex miRNA profiling assays. The launched assay has the ability to give high-throughput validation of miRNA biomarkers on the basis of Abcam’s new Firefly particle technology. Launching this product was the opportunities to Abcam for its Firefly particle technology that bring the global researchers for miRNA research.

  • On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, polymerase chain reaction (PCR), protein microarray and others.

    • In 2019, protein microarray segment is expected to dominate the global multiplex assays market with 34.2% market share and is expected to grow at the CAGR of 7.6% in the forecast period of 2019 to 2026. However, polymerase chain reaction (PCR) segment is expected to grow at the highest CAGR of 8.2% in the forecast period of 2019 to 2026.
    • In July 2018, BD (Becton, Dickinson and Company) launched BD AbSeq assay for simultaneous RNA and protein expression analysis assay. The systems include the BD Rhapsody Express system and the BD single-cell multiplexing kit. Launch of this product helped in increasing one more product in company’s product portfolio.

  • On the basis of application, the market is segmented into research & development and clinical diagnostics. Research & development is sub-segmented into drug discovery & development and biomarker discovery & validation. Clinical diagnostics is sub-segmented into infectious diseases, cancer, cardiovascular diseases, infectious diseases, autoimmune diseases, allergies, nervous system disorders, metabolism & endocrinology disorders and others.

    • In 2019, clinical diagnostics segment is expected to dominate the global multiplex assays market with 55.5% market share and is expected to grow at the highest CAGR of 7.8% in the forecast period of 2019 to 2026.
    • In June 2015, MESO SCALE DIAGNOSTICS, LLC. at the 2015 AAPS National Biotechnology Conference, launched its new Biomarker Services. This service offered biomarker screening and assay development services to their customer for discovery and exploratory studies to validated products.

  • On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, research institutes, hospitals, clinical laboratories and others. In 2019, hospitals segment is expected to dominate the global multiplex assays market with 36.0% market share and is expected to grow at the highest CAGR of 8.4% in the forecast period of 2019 to 2026.

    • In January 2016, Thermo Fisher Scientific acquired Affymetrix (U.S.). The acquisition of Affymetrix with Thermo Fisher Scientific helped Thermo Fisher Scientific Company in strengthening the biosciences field and creating new market opportunities for in genetic analysis.

Competitive Analysis: Global Multiplex Assays Market

Some of the prominent participants operating in this market are BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Cepheid, Siemens AG, Hologic Inc., Luminex Corporation. , MESO SCALE DIAGNOSTICS, LLC., QIAGEN, PerkinElmer Inc. , Illumina, Inc. , AGENA BIOSCIENCE, INC. , Olink , Randox Laboratories Ltd., Bio-Techne. , Agilent Technologies, Agilent Technologies, Sysmex Corporation and among others..

Product launch:

  • In June 2018, QIAGEN (Germany) launched the QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit. This kit was launched along with a new generation of reagents that allows the most accurate quantification and qualitative analysis from complex microbiome samples. This product provides a comprehensive and robust profiling of bacterial and fungal communities. With this launch, one more product got added to the company’s product portfolio.
  • In May 2018, Bio-Rad Laboratories, Inc. launched the Bio-Plex Pro Human Cytokine Screening Panel. This product is the first validated high-performance multiplex assay on the market. The panel has the ability to identify and quantify 48 different analytes. This is applicable for identification and estimation of analytes for heart disease, autoimmunity and allergy, cancer, and many other conditions. Launching this product helped the company in increasing their product portfolio.
  • In June 2018, QIAGEN launched the QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit. This kit was launched with a new generation of reagents to allow the most accurate microbial community profiling from complex microbiome samples. This product provides comprehensive and robust profiling of bacterial and fungal communities. With this launch one more product got added to company’s product portfolio.
  • In May 2017, Bio-Rad Laboratories, Inc. launched the Bio-Plex Pro Human Apolipoprotein Panel. This product has 10-plex panel that allows researchers to detect and quantify quickly key human apolipoproteins associated with cardiovascular disease, especially within the statin pathway. The panel offers the largest number of apolipoproteins on the market. It is one of the easiest way for detection for the problems related to cardiovascular and others and with this company has added one more product in their product portfolio for serving it to their customer in market.
  • In August 2017, Quanterix Corporation announced expansion for its single molecule array, or Simoa, technology platform portfolio by launching the new Quanterix SR-Plex benchtop instrument. Digital health revolution and life science research increased multiplexing capabilities. This launch enabled a transformation to asymptomatic medicine and precision health and also increased the company’s product portfolio.

Research Methodology: Global Multiplex Assays Market

Primary Respondents: Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers


SKU-

LIST OF TABLES GLOBAL MULTIPLEX ASSAYS MARKET

TABLE 1 COST OF FEW MULTIPLEX INSTRUMENTS TABLE 2 GLOBAL MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 3 GLOBAL REAGENTS & CONSUMABLES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 4 GLOBAL INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 5 GLOBAL INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 6 GLOBAL MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 7 GLOBAL NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 8 GLOBAL NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 9 GLOBAL PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 10 GLOBAL PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 11 GLOBAL CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 12 GLOBAL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 13 GLOBAL PROTEIN MICROARRAY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 14 GLOBAL POLYMERASE CHAIN REACTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 15 GLOBAL MULTIPLEX REAL-TIME PCR IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 16 GLOBAL FLOW CYTOMETRY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 17 GLOBAL FLUORESCENCE DETECTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 18 GLOBAL LUMINESCENCE IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 19 GLOBAL OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 20 GLOBAL MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 21 GLOBAL CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 22 GLOBAL CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 23 GLOBAL RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 24 GLOBAL RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 25 GLOBAL MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 26 GLOBAL HOSPITALS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 27 GLOBAL CLINICAL LABORATORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 28 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 29 GLOBAL RESEARCH INSTITUTES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 30 GLOBAL OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 31 GLOBAL MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 32 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 33 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 34 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 35 NORTH AMERICA NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 36 NORTH AMERICA PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 37 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 38 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 39 NORTH AMERICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 40 NORTH AMERICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 41 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 42 U.S. MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 43 U.S. MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 44 U.S. NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 45 U.S. PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 46 U.S. MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 47 U.S. MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 48 U.S. CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 49 U.S. RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 50 U.S. MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 51 CANADA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 52 CANADA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 53 CANADA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 54 CANADA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 55 CANADA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 56 CANADA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 57 CANADA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 58 CANADA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 59 CANADA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 60 MEXICO MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 61 MEXICO MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 62 MEXICO NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 63 MEXICO PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 64 MEXICO MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 65 MEXICO MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 66 MEXICO CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 67 MEXICO RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 68 MEXICO MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 69 EUROPE MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 70 EUROPE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 71 EUROPE MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 72 EUROPE NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 73 EUROPE PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 74 EUROPE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 75 EUROPE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 76 EUROPE CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 77 EUROPE RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 78 EUROPE MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 79 GERMANY MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 80 GERMANY MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 81 GERMANY NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 82 GERMANY PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 83 GERMANY MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 84 GERMANY MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 85 GERMANY CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 86 GERMANY RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 87 GERMANY MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 88 U.K. MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 89 U.K. MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 90 U.K. NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 91 U.K. PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 92 U.K. MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 93 U.K. MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 94 U.K. CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 95 U.K. RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 96 U.K. MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 97 FRANCE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 98 FRANCE MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 99 FRANCE NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 100 FRANCE PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 101 FRANCE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 102 FRANCE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 103 FRANCE CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 104 FRANCE RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 105 FRANCE MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 106 ITALY MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 107 ITALY MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 108 ITALY NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 109 ITALY PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 110 ITALY MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 111 ITALY MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 112 ITALY CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 113 ITALY RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 114 ITALY MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 115 SPAIN MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 116 SPAIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 117 SPAIN NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 118 SPAIN PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 119 SPAIN MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 120 SPAIN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 121 SPAIN CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 122 SPAIN RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 123 SPAIN MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 124 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 125 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 126 SWITZERLAND NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 127 SWITZERLAND PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 128 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 129 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 130 SWITZERLAND CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 131 SWITZERLAND RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 132 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 133 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 134 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 135 NETHERLANDS NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 136 NETHERLANDS PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 137 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 138 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 139 NETHERLANDS CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 140 NETHERLANDS RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 141 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 142 BELGIUM MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 143 BELGIUM MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 144 BELGIUM NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 145 BELGIUM PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 146 BELGIUM MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 147 BELGIUM MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 148 BELGIUM CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 149 BELGIUM RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 150 BELGIUM MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 151 IRELAND MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 152 IRELAND MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 153 IRELAND NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 154 IRELAND PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 155 IRELAND MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 156 IRELAND MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 157 IRELAND CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 158 IRELAND RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 159 IRELAND MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 160 AUSTRIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 161 AUSTRIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 162 AUSTRIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 163 AUSTRIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 164 AUSTRIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 165 AUSTRIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 166 AUSTRIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 167 AUSTRIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 168 AUSTRIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 169 REST OF EUROPE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 170 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 171 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 172 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 173 ASIA-PACIFIC NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 174 ASIA-PACIFIC PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 175 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 176 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 177 ASIA-PACIFIC CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 178 ASIA-PACIFIC RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 179 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 180 CHINA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 181 CHINA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 182 CHINA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 183 CHINA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 184 CHINA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 185 CHINA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 186 CHINA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 187 CHINA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 188 CHINA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 189 JAPAN MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 190 JAPAN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 191 JAPAN NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 192 JAPAN PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 193 JAPAN MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 194 JAPAN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 195 JAPAN CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 196 JAPAN RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 197 JAPAN MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 198 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 199 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 200 SOUTH KOREA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 201 SOUTH KOREA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 202 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 203 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 204 SOUTH KOREA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 205 SOUTH KOREA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 206 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 207 INDIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 208 INDIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 209 INDIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 210 INDIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 211 INDIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 212 INDIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 213 INDIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 214 INDIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 215 INDIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 216 SINGAPORE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 217 SINGAPORE MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 218 SINGAPORE NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 219 SINGAPORE PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 220 SINGAPORE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 221 SINGAPORE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 222 SINGAPORE CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 223 SINGAPORE RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 224 SINGAPORE MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 225 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 226 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 227 AUSTRALIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 228 AUSTRALIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 229 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 230 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 231 AUSTRALIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 232 AUSTRALIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 233 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 234 THAILAND MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 235 THAILAND MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 236 THAILAND NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 237 THAILAND PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 238 THAILAND MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 239 THAILAND MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 240 THAILAND CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 241 THAILAND RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 242 THAILAND MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 243 MALAYSIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 244 MALAYSIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 245 MALAYSIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 246 MALAYSIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 247 MALAYSIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 248 MALAYSIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 249 MALAYSIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 250 MALAYSIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 251 MALAYSIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 252 INDONESIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 253 INDONESIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 254 INDONESIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 255 INDONESIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 256 INDONESIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 257 INDONESIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 258 INDONESIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 259 INDONESIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 260 INDONESIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 261 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 262 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 263 PHILIPPINES NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 264 PHILIPPINES PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 265 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 266 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 267 PHILIPPINES CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 268 PHILIPPINES RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 269 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 270 REST OF ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 271 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 272 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 273 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 274 SOUTH AMERICA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 275 SOUTH AMERICA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 276 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 277 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 278 SOUTH AMERICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 279 SOUTH AMERICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 280 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 281 BRAZIL MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 282 BRAZIL MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 283 BRAZIL NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 284 BRAZIL PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 285 BRAZIL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 286 BRAZIL MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 287 BRAZIL CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 288 BRAZIL RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 289 BRAZIL MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 290 REST OF SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 291 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 292 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 293 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 294 MIDDLE EAST & AFRICA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 295 MIDDLE EAST & AFRICA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 296 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 297 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 298 MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 299 MIDDLE EAST & AFRICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 300 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 301 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 302 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 303 SOUTH AFRICA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 304 SOUTH AFRICA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 305 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 306 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 307 SOUTH AFRICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 308 SOUTH AFRICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 309 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 310 REST OF MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19